The UTCG inaugurates new cGMP suites
On Wednesday 13 March 2019, guests were gathered to inaugurate cGMP suites, the 400m² dedicated to cellular and gene therapy.
The facilities are specialized in the development of advanced therapy medicinal products (ATMP) and were designed to produce therapeutic cells, including genetically modified ones, for phase I or II clinical trials. The intention is to evolve in the future towards a model which accompanies projects holders (academic, biotech industries) in clinical trials.
Many projects in the field of oncology, autoimmune diseases or regenerative medicine are presently being produced at UTCG.
#CHU de Nantes #GMP #cell therapy